Antimicrobial polypeptide, nucleic acid, and methods of use

Details Antimicrobial polypeptide, nucleic acid, and methods of use Antimicrobial polypeptide, nucleic acid, and methods of use

2005-11-15

2005-11-15

Spector, Lorraine (Department: 1647)

Drug, bio-affecting and body treating compositions

Dentifrices

C424S050000, C514S013800, C530S326000

Reexamination Certificate

active

06964760

ABSTRACT:
Antimicrobial compounds and compositions and uses thereof, including the treatment and prevention of bacterial infections are described. The compounds and compositions include lantibiotic polypeptides and the nucleic acid sequences encoding the polypeptides. The compounds and compositions are useful as antimicrobials in antibiotic pharmaceutical preparation and as an antimicrobial or antiseptic dentifrice.

REFERENCES:
patent: 5352450 (1994-10-01), Koga et al.
patent: 5650320 (1997-07-01), Caufield et al.
patent: 6218362 (2001-04-01), Lavoie et al.
patent: 6391285 (2002-05-01), Hillman
patent: 0 543 195 (1992-10-01), None
patent: WO 96/40865 (1996-12-01), None
patent: WO 98/17685 (1998-04-01), None
Rudinger. InPeptide Hormones, J. A. Parsons, ed. University Park Press, Baltimore, pp. 1-7, 1976.
European Search Report for European Patent Application 98928967.3-2106-US9812003.
EMBL database entry AAP91366.
Gutierrez, et al., “Insertional Mutagenesis and Recovery of Interrupted Genes of Streptococcus mutans by Using Transposon Tn917: Preliminary Characterization of Mutants Displaying Acid Sensitivity and Nutritional Requirements” Journal of Bacteriology, vol. 178, No. 14, pp. 4166-4175, Jul. 1997.
Mota-Meira et al., “Purification and Structure of Mutacin B-Ny266: A New Lantibiotic Produced by Streptococcus Mutans”, FEBS Letters, 410, pp. 275-279, Feb. 1997.
Hillman, et al., “Genetic and Biochemical Analysis of Mutacin 1140, A Lantibiotic from Streptococcus Mutans”, Infection and Immunity, vol. 66, No. 6, pp. 2743-2749, Nov. 1997.
Smith, et al., “Probing Structural Heterogeneity in Mutacin 1140, a Novel Lantibiotic”. Fortieth International Experimental Nuclear Magnetic Resonance Conference, Orlando, Florida, Feb. 28-Mar. 5, P034-73 (1999).
Smith, et al., “Covalent and Initial Three-Dimensional Structure of the Lantibiotic Mutacin 1140”, Southeast Magnetic Resonance Conference, Tallahassee, Florida P45-102, Fall (1999).
Mota-Meira, et al., “MICs of Mutacin B-Ny266, Nisin A, Vancomycin, and Oxacillin against Bacterial Pathogens”, Antimicrobial Agents and Chemotherapy, pp. 24-29, Jan. 2000.
Smith, et al., “Covalent Structure of Mutacin 1140 and a Novel Method for the Rapid Identification of Lantibiotics”, Eur. J. Biochem., 267, pp. 6810-6816, 2000.

Affiliated with

Also associated with

Rating

Antimicrobial polypeptide, nucleic acid, and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antimicrobial polypeptide, nucleic acid, and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial polypeptide, nucleic acid, and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3452222